Full-field digital mammography (FFDM) has been the “go to” imaging modality to screen for early detection of breast cancer for […]
Full-field digital mammography (FFDM) has been the “go to” imaging modality to screen for early detection of breast cancer for […]
On 23 December 2021, the board of directors of RSNA announced that Dr Linda Moy (seen right) would become editor of their […]
It was five years ago that we published a key article in Diagnostics, an open-access journal, in which we described our dual-modality […]
The Merriam-Webster dictionary provides three essential meanings for the word “density”: having parts that are close together; being difficult to see through; […]
We are all familiar with the expression, “killing two birds with one stone,” which means to achieve two things by […]
Earlier this year, we described how the digital breast tomosynthesis (DBT) pioneers, led by Dr Daniel Kopans, developed a screening tool that […]
Judging by their marketing, companies are gearing up for widespread adoption of their artificial intelligence (AI) algorithms by breast screening […]
Six years ago, we reviewed a paper published in The Lancet by the Japan Strategic Anti-Cancer Randomized Trial (J-START) in which the […]
Ten years ago, on 15 August 2011, we posted a blog on our website entitled “To screen or not to screen? That […]
Four years ago, we contributed a blog entitled “From land mines to breast cancer” in which we described a system from UK […]